Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Needle-free Injection System Market offers comprehensive insights into the market landscape, ...

It will grow to $26.33 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%.” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- ...

Vaccinating children is always a challenging task, especially when it involves needles, as they can make the process more unpleasant. But when a toddler somewhere in eastern India slept throughout her ...

A 2019 review notes that subcutaneous injections into the abdomen are typically less painful than those into the thigh. When starting Emgality injections, it may be helpful to try different locations.

Subcutaneous injection. Insulin is given as a subcutaneous injection — or just under the skin — so the needle doesn’t go into muscle, which could affect your blood sugar levels.

"We are delighted that the subcutaneous injection of VYVGART® co-formulated with our ENHANZE drug delivery technology, has been recommended for approval in the European Union.

By Halozyme Therapeutics, Inc. Apr 28, 2025 Apr 28, 2025Updated Apr 28, 2025 ...

Sublingual delivery of epinephrine achieved pharmacokinetic and pharmacodynamic results that were comparable with manual intramuscular injection and autoinjectors, according to a study published ...

FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.

News PR Newswire Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist ...

The paper, “Development of Repetitive Mechanical Oscillation Needle-Free Injection through Electrically Induced Microbubbles” was published in the journal Cyborg and Bionic Systems on Mar. 19 ...

In the phase 1 study, the two once-yearly formulations were given to 20 individuals each. At the end of the one-year mark, median concentration of lenacapavir in the blood was 57 ng/mL and 65.5 ng ...